164 related articles for article (PubMed ID: 9455458)
1. [Complementary scintigraphic examinations (99mTc-MDP, 99mTc-MIBI and Octreoscan) in breast neoplasm assessment].
Stefănescu C; Chossiere L; Rusu V; Meignan M
Rev Med Chir Soc Med Nat Iasi; 1996; 100(3-4):165-8. PubMed ID: 9455458
[TBL] [Abstract][Full Text] [Related]
2. 99mTc-MIBI and 99mTc-MDP scintimammography for detecting breast carcinoma.
Chen S; Liu W; Mao Y; Zhu W; Yao Z; Sun X; Xiu Y; Yin Y; Chen J
Chin Med J (Engl); 2000 May; 113(5):400-3. PubMed ID: 11776092
[TBL] [Abstract][Full Text] [Related]
3. Tc-99m sestamibi and In-111 DTPA octreotide uptake in breast carcinoma with neurendocrine differentiation.
Rubini G; D'Eredità G
Clin Nucl Med; 2000 Jun; 25(6):482-3. PubMed ID: 10836705
[TBL] [Abstract][Full Text] [Related]
4. The comparison of dual phase Tc-99m MIBI and tc-99m MDP scintimammography in the evaluation of breast masses: preliminary report.
Arslan N; Ozturk E; Ilgan S; Narin Y; Dundar S; Tufan T; Pekcan M; Bayhan H
Ann Nucl Med; 2000 Feb; 14(1):39-46. PubMed ID: 10770579
[TBL] [Abstract][Full Text] [Related]
5. [Value of scintigraphic explorations by radiomarkers others than iodine radioisotope in differentiated thyroid cancer].
Sassolas G; Houzard C; Sigartau C; Borson-Chazot F
Ann Endocrinol (Paris); 1997; 58(1):55-63. PubMed ID: 9207967
[TBL] [Abstract][Full Text] [Related]
6. [The prognostic significance of 99mTc-MDP breast scintigraphy. A comparison with histological and molecular parameters].
Dimonte M; Leo G; Marsigliante S; Manca C
Radiol Med; 1999 Nov; 98(5):352-5. PubMed ID: 10780214
[TBL] [Abstract][Full Text] [Related]
7. Breast parenchymal activity on scintimammography: comparison between bone-seeking agents and 99mTc-sestamibi.
Inoue Y; Katayama N; Yoshioka N; Yoshikawa K; Kashima M; Shimizu T; Tsukune Y; Ohtomo K
Ann Nucl Med; 1999 Dec; 13(6):453-6. PubMed ID: 10656284
[TBL] [Abstract][Full Text] [Related]
8. Indium-111-DTPA-D-Phe-1-octreotide and technetium-99m-(V)-dimercaptosuccinic acid scanning in the preoperative staging of medullary thyroid carcinoma.
Kurtaran A; Scheuba C; Kaserer K; Schima W; Czerny C; Angelberger P; Niederle B; Virgolini I
J Nucl Med; 1998 Nov; 39(11):1907-9. PubMed ID: 9829581
[TBL] [Abstract][Full Text] [Related]
9. [Diagnostic value of 99mTc-methoxy-isobutyl-isonitril and 99mTc-methylene diphosphonate scintimammography in the preoperative evaluation of breast cancer].
Schmidt E; Kett K; Anga B; Bódis J; Zámbó K
Orv Hetil; 2003 Apr; 144(17):787-92. PubMed ID: 12762063
[TBL] [Abstract][Full Text] [Related]
10. Primary osteogenic sarcoma of breast detected on Tc-99m MIBI scintigraphy and Tc-99m MDP skeletal scintigraphy.
Yang JG; Li CL; Hao RR; Zou LF
Ann Nucl Med; 2008 Jan; 22(1):79-82. PubMed ID: 18250991
[TBL] [Abstract][Full Text] [Related]
11. Correlation of 99mTc-sestamibi uptake with blood-pool and osseous phase 99mTc-MDP uptake in malignant bone and soft-tissue tumours.
Ozcan Z; Burak Z; Erinç R; Dirlik A; Başdemir G; Sabah D; Ozkiliç H
Nucl Med Commun; 2001 Jun; 22(6):679-83. PubMed ID: 11403180
[TBL] [Abstract][Full Text] [Related]
12. [Tumor imaging in nuclear medicine].
Uno K; Kuyama J; Uchida Y; Sakata S; Kitakata Y
Nihon Rinsho; 1996 May; 54(5):1268-72. PubMed ID: 8965349
[TBL] [Abstract][Full Text] [Related]
13. Acquisition protocol for breast cancer imaging with technetium-99m-labeled synthetic peptide and technetium-99m-MDP.
Fiorenza M; Prisco G; Bartolomei M; Chinol M; Cremonesi M; Leonardi L; De Cicco C; Paganelli G
J Nucl Med Technol; 1997 Sep; 25(3):191-4. PubMed ID: 9291065
[TBL] [Abstract][Full Text] [Related]
14. Comparison of indium-111 octreotide and thallium-201 scintigraphy in patients mammographically suspected of having breast cancer: preliminary results.
Vural G; Unlü M; Atasever T; Ozur I; Ozdemir A; Gökçora N
Eur J Nucl Med; 1997 Mar; 24(3):312-5. PubMed ID: 9143470
[TBL] [Abstract][Full Text] [Related]
15. Mammography and 99mTc-MIBI scintimammography in suspected breast cancer.
Mirzaei S; Knoll P; Lipp RW; Köhn H
J Nucl Med; 2000 Feb; 41(2):390-1. PubMed ID: 10688127
[No Abstract] [Full Text] [Related]
16. Intense uptake of technetium-99m-MDP in primary breast adenocarcinoma with sarcomatoid metaplasia.
Pickhardt PJ; McDermott M
J Nucl Med; 1997 Apr; 38(4):528-30. PubMed ID: 9098196
[TBL] [Abstract][Full Text] [Related]
17. Axillary node metastasis detection in breast cancer with 99mTc-sestaMIBI and 111In-pentetreotide.
Chiti A; Maffioli LS; Agresti R; Spinelli A; Savelli G; Casteliani MR; Giovanazzi R; Greco M; Bombardieri E
Tumori; 1997; 83(2):537-8. PubMed ID: 9226013
[No Abstract] [Full Text] [Related]
18. Scintimammography with 99mTc-MDP in the detection of primary breast cancer.
Piccolo S; Lastoria S; Muto P; Bazzicalupo L; Bartiromo A; Salvatore M
Q J Nucl Med; 1997 Sep; 41(3):225-30. PubMed ID: 9274130
[TBL] [Abstract][Full Text] [Related]
19. Abundant blood supply and low P-glycoprotein expression on dynamic 99mTc-MIBI imaging predicted better chemotherapy sensitivity for a breast cancer patient: a case report.
Si H; Li X
J Nucl Med Technol; 2012 Jun; 40(2):89-91. PubMed ID: 22505488
[TBL] [Abstract][Full Text] [Related]
20. Tc-99m MIBI filling pattern in a photopenic area of a Tc-99m MDP scan in a patient with metastatic bone involvement of breast carcinoma.
Durmus Altun G; Uzal C; Hacimahmutoglu S; Pekindil G; Sarikaya A; Omer Yigitbasi N
Clin Nucl Med; 2002 May; 27(5):381-2. PubMed ID: 11953584
[No Abstract] [Full Text] [Related]
[Next] [New Search]
